Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2016-04-04 Regulatory Filings
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Gulf Pharmaceutical Industries. Announcement of AGM to be held on April 28,2016 at 10:00 AM
Regulatory Filings
2016-04-04 English
وقف التداول موقتا علي أسهم شركة شركة الخليج للصناعات الدوائية في 28/04/2016
Regulatory Filings Classification · 95% confidence The document is a resolution concerning the temporary suspension of trading of shares of Gulf Pharmaceutical Industries due to the scheduling of the company's Annual General Meeting (AGM). It references the trading suspension starting before the AGM and lasting until the AGM results are received by the exchange. The document is a regulatory announcement about trading suspension related to the AGM event, not the AGM materials themselves or the AGM results. It is also short (1836 characters) and does not contain financial data or detailed AGM information. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement related to trading suspension and AGM scheduling, not the AGM information or report itself.
2016-04-04 Arabic
Temporary Suspension of Trading on The shares of Gulf Pharmaceutical Industries. on 28/04/2016
Regulatory Filings Classification · 95% confidence The document is a resolution concerning the temporary suspension of trading on the shares of Gulf Pharmaceutical Industries due to the timing of the company's AGM. It references the AGM date and the suspension of trading until AGM results are received. The document is short (1836 characters) and is an official announcement related to the AGM event, specifically about trading suspension rather than the AGM materials or results themselves. It does not contain AGM materials or results, nor detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement related to trading suspension around the AGM, not the AGM information itself or the AGM results.
2016-04-04 English
وقف التداول موقتا علي أسهم شركة شركة الخليج للصناعات الدوائية في 31/03/2016
Delisting Announcement Classification · 95% confidence The document is a formal resolution from a regulatory authority (ADX) concerning the temporary suspension of trading of shares of Gulf Pharmaceutical Industries due to the company's failure to submit its financial statement. It references regulatory articles and mandates the suspension starting from a specific date. This is an official announcement about trading suspension, which fits the definition of a Delisting Announcement or trading suspension notice. Given the content and context, the document is best classified as a Delisting Announcement (DLST). The document length is short and it is not a full financial report or an announcement of a report publication, but a regulatory action notice.
2016-04-03 Arabic
Temporary Suspension of Trading on The shares of Gulf Pharmaceutical Industries. on 31/03/2016
Delisting Announcement Classification · 95% confidence The document is a formal resolution from a regulatory or exchange authority (ADX) concerning the temporary suspension of trading of shares of Gulf Pharmaceutical Industries due to the company's failure to submit its financial statement. It references regulatory articles and specifies the suspension start date. This is an official announcement about trading suspension, which fits the definition of a Delisting Announcement or trading suspension notice. Given the content focuses on suspension of trading rather than delisting per se, but the closest category is Delisting Announcement (DLST) as it involves removal or suspension of stock trading on an exchange.
2016-04-03 English
شركة الخليج للصناعات الدوائية نتائج اجتماع مجلس الإدارة 30 مارس,2016 الساعة 10:00 صباحاً
Regulatory Filings
2016-03-30 Arabic

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.